Figure 4
Relapse risk and relapse-free survival by residual disease (RD) status at the end of induction 2. Relapse risk and relapse-free survival by residual disease status at the end of induction 2 (A-B) and at the end of therapy (C-D).
Relapse risk and relapse-free survival by residual disease (RD) status at the end of induction 2. Relapse risk and relapse-free survival by residual disease status at the end of induction 2 (A-B) and at the end of therapy (C-D).
